Chiba Medical J. 93E:25~29,2017
doi:10.20776/S03035476-93E-3-P25
[ Original Paper ]
Yasushi Wako1,2), Junichi Nakamura1), Hitoshi Kitazaki2),
Makoto Takazawa3), Gen Arai2), Shuichi Miyamoto1), Michiaki Miura1),
Seiji Ohtori1) ,Takane Suzuki4),Takayuki Nakajima3), Sumihisa Orita1)
and Kazuhisa Takahashi1)
1) Department of Orthopedic Surgery, Graduate School of Medicine, Chiba University,Chiba 260-8670.
2) Department of Orthopedic Surgery, Chiba Prefectural Sawara Hospital, Katori 287-0003.
3) Department of Orthopedic Surgery, Eastern Chiba Medical Center, Togane 283-8686.
4) Department of Bioenvironmentral medicine, Graduate School of Medicine, Chiba University, Chiba 260-8677.
Received December 1, 2016, Accepted January 13, 2017)
With a progressively aging society, the number of hip fractures in Japan has dramatically increased. The purpose of this study was to examine survivorship and walking ability of patients older than 95 years after surgical or conservative treatment for hip fractures. We retrospectively investigated the medical records of 44 patients6 men and 38 women) with hip fracture who were aged 95 years and older between October 2008 and September 2013. Surgery was performed on 31 patients and 13 patients were treated conservatively. We examined survivorship of patients in surgical and conservative groups and their ability to walk after one year. Survivorship at one year was significantly higher in the surgical group than in the conservative group70% versus 38%, P<0.05). In the surgical group, the survivorship of the postoperative ambulators was significantly higher than that of nonambulators 100% versus 51%, P<0.05). Overall, ambulation was regained in 43% of patients who could walk before injury. The prognostic factor for reambulation was the level of walking ability before injury. Surgical treatment can improve life expectancy and walking ability after hip fracture, especially in elderly patients who could walk before their hip fracture injury.
Hip fracture, 95years old and older, Survivorship
The number of hip fractures has dramatically increased with progressive aging of society. It is estimated that about 25 million people in Japan will suffer from hip fractures in 2020, about 30 million in 2030, and about 32 million in 2042[1,2]. In general, surgery is the criterion standard treatment for hip fracture if patients are in good health. It is not rare to choose surgical treatment, although surgery for elderly patients has some risk. Previous studies have reported outcomes of hip fracture in patients aged 90 years and older [3-11]. However, to the best of our knowledge, there have been no reports regarding surgical treatment of patients aged 95 years old and older. The purpose of this study was therefore to compare the survivorship and walking ability in patients aged 95 years and older after surgical or conservative treatment.
We retrospectively investigated the medical records of 44 patients treated for hip fracture in our institution, who were aged 95 years and older between October 2008 and September 2013. Initially, surgical treatment was considered for all of these patients. However, 13 patients were treated conservatively because of poor general health, low activity of daily livingfor example, bedridden) before injury or refusal of surgery by the patients or their family. Thirty-one patients were treated surgically. Open reduction and internal fixation were performed for intertrochanteric fracture and stable femoral neck fractureGarden stage 1 or 2). Hemiarthroplasty was performed for unstable femoral neck fracturesGarden stage 3 or 4). Most patients began rehabilitation from the first postoperative day with full weight bearing. Rehabilitation was discontinued when their walking abilities had recovered to their preinjury level or plateaued. The plateau level was defined as the final walking ability.
In the surgical group, we investigated walking ability after surgery. Walking ability was classified into three levels using a modification of the methods described by Ishida et al. 3: Group 1 for bedridden or using a wheeling chair, Group 2 for using a walker, and Group 3 for unaided walking or using a cane. In this study, we defined Group 1 as nonambulators, and Group 2 and 3 as ambulators. We compared various factors affecting walking ability: age, time between fracture and surgery, blood hemoglobinHb), serum albumin Alb), type of fracture, dementia, and walking ability before fracture between ambulators and nonambulators. We also compared the mortality of ambulators and nonambulators.
Conservative treatment consisted of bedrest without traction and bedside rehabilitation, which included upper and lower muscle training. Subsequently, patients were allowed to use a wheelchair with assistance depending on their pain.
Statistical analyses were conducted using a χ2 or Mann-Whitney U test. Mortality outcome of surgical and conservative treatments was compared using Kaplan-Meier methods. In all statistical analyses, P< 0.05 was considered significant.
The characteristics of patients in the surgical and conservative groups are shown in (Table 1). Surgical group consisted of thirty-one patients and conservative group consisted of thirteen patients. The sex, age, mean blood hemoglobinHb) level and mean serum albumin Alb) at admission were not significantly different between two groups. In the surgical group, the rate of trochanteric fractures was significantly higher than the conservative groupP=0.02). In the surgical group, the rate of dementia at admission was significantly lower than the conservative groupP=0.02). In the surgical group, walking ability before injury was significantly higher than conservative groupP=0.01).
At a mean follow-up of 13.7 monthsrange, 1 to 58 months), of 31 patients in the surgical group, 21 patients were classified into Group 3, 7 into Group 2, and 3 into Group 1 as preoperative walking ability. In Group 3, 11 patients52%) were ambulatory, in Group 2, 114%) was ambulatory, and in Group 1, none were ambulatory after surgery. Group 3 patients showed higher ambulatory ability, but the difference was not significant. In the conservative group, none were ambulatory after injury. In surgical group, 12 43%) of the 28 patients, who were ambulatory before injury, regained their ambulatory ability in Group 2 or 3 after treatment (Table 2). There were no significant diff rences in mean age, mean time between fracture and surgery, mean Hb before surgery, mean Alb before surgery, type of fractures, and dementia between ambulators and nonambulators.
One-year survival rate was significantly higher in the surgical group than in the conservative group70% versus 38%, P=0.036, Figure 1). Moreover, in the surgical group, one-year survival rate was significantly higher in postoperative ambulators than in postoperative nonambulators100% versus 51%, P=0.01, Figure2). In the conservative group, 6-month survival rate was only 46%.
Fig. 1 Comparison of survival rate of surgical and conservative treatment
One-year survival rate was 70% in the surgical group and significantly different from the 38% in the conservative group P=0.04, Kaplan-Meier method)
To our knowledge, this study is the first report of outcomes of hip fracture in patients who were aged 95 years or older at the time of their injury. We showed that despite their old age, it was possible to obtain favorable outcome of 43% reambulation after surgery. Hagino et al. reported that generally 60% to 80% of patients were ambulatory after surgery. However, the rate fell to 25%-41% for patients aged 90 years and older[4]. Other studies found that 25%-71% of patients aged 90 years and older were ambulatory after surgery[5,8,10]. MacCollum et al. reported that 25% of 52 patients aged 90 years and older with hip fractures were ambulatory after surgery[5]. Shah et al[8]. and Intiso et al[10]. reported a postoperative ambulatory rate of 41% and 71%. We consider our results are acceptable for patients aged 95 years and older.
Walking ability before injury appeared to be predictive for ambulation after treatment in this study. Factors including dementia[3,11], type of fracture, time between fracture and surgery, Hb, Alb[15,16], have been reported as influential, but they remain controversial.
Postoperative ambulation was a prognostic factor for one-year survival at 100%. Generally, in elderly patients with hip fractures, one-year survival rate is about 90%[12,13,14]. However, in patients aged 90 years and older, this decreases to 54%-75%[5,8,9,11]. MacCollum et al. reported a one-year survival rate of 54% after surgery in patients aged 90 years and older. Jenning et al. and Torplliesi et al. reported that it was 54% and 75%, respectively. In this study, despite the age of the patients, one-year survival rate after surgery was 70%, which is consistent with earlier findings in younger patients. We can expect an equivalent survival rate after surgery even in patients aged 95 years and older.
Conservative treatment for hip fracture is considered to have a poor prognosis for survival. Previous studies reported the natural history after hip fracture was miserable, with a one-year survival of about 40%-80% [17-19]. In the present study, 6-month survival was 46% and one-year survival was 38%. The generally worse condition and lower walking ability of patients who were treated conservatively compared with patients who could undergo surgery may explain the poor prognosis. Therefore, it cannot be said that the conservative treatment itself causes a poor outcome. Nevertheless, we recommend surgical treatment for hip fractures even in patients 95 years and older. We believe that a predicted survival of 70% after one year is valid for older patients who undergo invasive treatment.
This study has several limitations. First, because of its retrospective nature, the decision for surgical or conservative treatment was the surgeon’s preference. Thus, we must admit there was a selection bias between the two groups. Second, this is small number study, we think further study is needed.
In conclusion, surgical treatment can restore walking ability after hip fracture, and can improve life expectancy in postoperative ambulators who are aged 95 years and older.
Address correspondence to Dr. Junichi Nakamura.
Department of Orthopedic Surgery, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba
260-8670, Japan.
Phone: +81-43-226-2117. Fax: +81-43-226-2116.
E-mail:njonedr@chiba-u.jp